AAAAAA

   
Results: 1-9 |
Results: 9
p53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma
Authors: Elsaleh, H Powell, B McCaul, K Grieu, F Grant, R Joseph, D Iacopetta, B
Citation: H. Elsaleh et al., p53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma, CLIN CANC R, 7(5), 2001, pp. 1343-1349
Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients
Authors: Powell, BL Bydder, S Grieu, F Gnanasampanthan, G Elsaleh, H Seshadri, R Berns, EMJJ Iacopetta, B
Citation: Bl. Powell et al., Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients, BREAST CANC, 69(1), 2001, pp. 65-68
A polymorphism in the enhancer region of the thymidylate synthase promoterinfluences the survival of colorectal cancer patients treated with 5-fluorouracil
Authors: Iacopetta, B Grieu, F Joseph, D Elsaleh, H
Citation: B. Iacopetta et al., A polymorphism in the enhancer region of the thymidylate synthase promoterinfluences the survival of colorectal cancer patients treated with 5-fluorouracil, BR J CANC, 85(6), 2001, pp. 827-830
Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformationpolymorphism
Authors: Iacopetta, B Elsaleh, H Grieu, F Joseph, D Sterrett, G Robbins, P
Citation: B. Iacopetta et al., Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformationpolymorphism, DIAGN MOL P, 9(1), 2000, pp. 20-25
Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP
Authors: Iacopetta, B Grieu, F
Citation: B. Iacopetta et F. Grieu, Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP, BIOTECHNIQU, 28(3), 2000, pp. 566
Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?
Authors: Elsaleh, H Robbins, P Joseph, D Powell, B Grieu, F Menso, L Iacopetta, B
Citation: H. Elsaleh et al., Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?, RADIOTH ONC, 56(2), 2000, pp. 239-244
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
Authors: Elsaleh, H Joseph, D Grieu, F Zeps, N Spry, N Iacopetta, B
Citation: H. Elsaleh et al., Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer, LANCET, 355(9217), 2000, pp. 1745-1750
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas
Authors: Elsaleh, H Soontrapornchai, P Grieu, F Joseph, D Iacopetta, B
Citation: H. Elsaleh et al., P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas, INT J ONCOL, 15(6), 1999, pp. 1239-1243
P53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma
Authors: Powell, B Soong, R Grieu, F Knowles, S Hammond, I Iacopetta, B
Citation: B. Powell et al., P53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma, INT J ONCOL, 14(1), 1999, pp. 175-179
Risultati: 1-9 |